Picture of CellaVision AB logo

CEVI — CellaVision AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapHigh Flyer

Brief: CellaVision Q4 EBITDA SEK 61 Million

Feb 06 (Reuters) - CellaVision Q4 adjusted EPS SEK 1.72.
* Q4 pretax profit SEK 51 million
* Q4 EBITDA margin 33%
* Q4 sales SEK 187 million

Recent news on CellaVision AB

See all news